Bifogade filer
PDF
Kurs & Likviditet
Kalender
| 2024-11-13 | Kvartalsrapport 2024-Q3 |
| 2024-08-21 | Kvartalsrapport 2024-Q2 |
| 2024-05-15 | Kvartalsrapport 2024-Q1 |
| 2024-03-21 | Ordinarie utdelning HLUN A 0.70 DKK |
| 2024-03-21 | Ordinarie utdelning HLUN B 0.70 DKK |
| 2024-03-20 | Årsstämma 2024 |
| 2024-02-07 | Bokslutskommuniké 2023 |
| 2023-11-08 | Kvartalsrapport 2023-Q3 |
| 2023-08-16 | Kvartalsrapport 2023-Q2 |
| 2023-05-10 | Kvartalsrapport 2023-Q1 |
| 2023-03-22 | Ordinarie utdelning HLUN A 0.58 DKK |
| 2023-03-22 | Ordinarie utdelning HLUN B 0.58 DKK |
| 2023-03-21 | Årsstämma 2023 |
| 2023-02-08 | Bokslutskommuniké 2022 |
| 2022-11-09 | Kvartalsrapport 2022-Q3 |
| 2022-08-17 | Kvartalsrapport 2022-Q2 |
| 2022-06-10 | Split HLUN B 1:5 |
| 2022-06-08 | Extra Bolagsstämma 2022 |
| 2022-05-11 | Kvartalsrapport 2022-Q1 |
| 2022-03-24 | Ordinarie utdelning HLUN B 2.00 DKK |
| 2022-03-23 | Årsstämma 2022 |
| 2022-02-09 | Bokslutskommuniké 2021 |
| 2021-11-10 | Kvartalsrapport 2021-Q3 |
| 2021-08-18 | Kvartalsrapport 2021-Q2 |
| 2021-05-11 | Kvartalsrapport 2021-Q1 |
| 2021-03-24 | Ordinarie utdelning HLUN B 2.50 DKK |
| 2021-03-23 | Årsstämma 2021 |
| 2021-02-04 | Bokslutskommuniké 2020 |
| 2020-11-03 | Kvartalsrapport 2020-Q3 |
| 2020-08-13 | Kvartalsrapport 2020-Q2 |
| 2020-05-12 | Kvartalsrapport 2020-Q1 |
| 2020-03-25 | Ordinarie utdelning HLUN B 4.10 DKK |
| 2020-03-24 | Årsstämma 2020 |
| 2020-02-06 | Bokslutskommuniké 2019 |
| 2019-11-05 | Kvartalsrapport 2019-Q3 |
| 2019-08-14 | Kvartalsrapport 2019-Q2 |
| 2019-05-08 | Kvartalsrapport 2019-Q1 |
| 2019-03-27 | Ordinarie utdelning HLUN B 12.00 DKK |
| 2019-03-26 | Årsstämma 2019 |
| 2019-02-05 | Bokslutskommuniké 2018 |
| 2018-11-07 | Kvartalsrapport 2018-Q3 |
| 2018-08-08 | Kvartalsrapport 2018-Q2 |
| 2018-05-08 | Kvartalsrapport 2018-Q1 |
| 2018-03-21 | Ordinarie utdelning HLUN B 8.00 DKK |
| 2018-03-20 | Årsstämma 2018 |
| 2018-02-07 | Bokslutskommuniké 2017 |
| 2017-11-08 | Kvartalsrapport 2017-Q3 |
| 2017-08-09 | Kvartalsrapport 2017-Q2 |
| 2017-05-10 | Kvartalsrapport 2017-Q1 |
| 2017-03-31 | Ordinarie utdelning HLUN B 2.45 DKK |
| 2017-03-30 | Årsstämma 2017 |
| 2017-02-08 | Bokslutskommuniké 2016 |
| 2016-11-02 | Kvartalsrapport 2016-Q3 |
| 2016-08-24 | Kvartalsrapport 2016-Q2 |
| 2016-05-11 | Kvartalsrapport 2016-Q1 |
| 2016-04-01 | Ordinarie utdelning HLUN B 0.00 DKK |
| 2016-03-31 | Årsstämma 2016 |
| 2016-02-10 | Bokslutskommuniké 2015 |
| 2015-11-04 | Kvartalsrapport 2015-Q3 |
| 2015-08-19 | Kvartalsrapport 2015-Q2 |
| 2015-05-06 | Kvartalsrapport 2015-Q1 |
| 2015-03-26 | Ordinarie utdelning HLUN B 0.00 DKK |
| 2015-03-25 | Årsstämma 2015 |
| 2015-02-05 | Bokslutskommuniké 2014 |
| 2014-11-05 | Kvartalsrapport 2014-Q3 |
| 2014-08-07 | Kvartalsrapport 2014-Q2 |
| 2014-05-07 | Kvartalsrapport 2014-Q1 |
| 2014-03-27 | Ordinarie utdelning HLUN B 2.77 DKK |
| 2014-03-26 | Årsstämma 2014 |
| 2014-02-06 | Bokslutskommuniké 2013 |
| 2013-11-06 | Kvartalsrapport 2013-Q3 |
| 2013-08-07 | Kvartalsrapport 2013-Q2 |
| 2013-05-01 | Kvartalsrapport 2013-Q1 |
| 2013-03-22 | Ordinarie utdelning HLUN B 2.00 DKK |
| 2013-03-21 | Årsstämma 2013 |
| 2013-02-06 | Bokslutskommuniké 2012 |
| 2012-11-07 | Kvartalsrapport 2012-Q3 |
| 2012-08-08 | Kvartalsrapport 2012-Q2 |
| 2012-05-02 | Kvartalsrapport 2012-Q1 |
| 2012-03-30 | Ordinarie utdelning HLUN B 3.49 DKK |
| 2012-03-29 | Årsstämma 2012 |
| 2012-02-08 | Bokslutskommuniké 2011 |
| 2011-11-09 | Kvartalsrapport 2011-Q3 |
| 2011-08-10 | Kvartalsrapport 2011-Q2 |
| 2011-05-04 | Kvartalsrapport 2011-Q1 |
| 2011-03-31 | Ordinarie utdelning HLUN B 3.77 DKK |
| 2011-03-30 | Årsstämma 2011 |
| 2010-04-21 | Ordinarie utdelning HLUN B 3.07 DKK |
| 2009-04-22 | Ordinarie utdelning HLUN B 2.30 DKK |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
H. Lundbeck A/S (Lundbeck) announces that Elise Hauge, Executive Vice President, People & Communication has decided to depart Lundbeck.
She will leave Lundbeck no later than Dec 31, 2023.
"I want to personally thank Elise for her strong dedication and hard work with both P&O as well as Communication in Lundbeck. She has really made a difference for us across both departments during the last 4 years, and both functions now have a strong foundation to build on, when it comes to strengthening the communication of Lundbeck's role in restoring brain health. We wish Elise the very best of all in her future endeavors," says Deborah Dunsire, CEO at Lundbeck.
The search for a successor has been initiated and a new EVP and Chief People officer at Lundbeck will be announced in due course.
Contacts
Thomas Mikkel Mortensen Palle Holm Olesen
Media Relations Lead, Corp. Communication Vice President, Investor Relations
THMR@lundbeck.com PALO@lundbeck.com
+45 30 83 30 24 +45 30 83 24 26
About H. Lundbeck A/S
Lundbeck is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research.
We are tirelessly dedicated to restoring brain health, so every person can be their best. We are committed to fighting stigma and discrimination against people living with brain diseases and advocating for broader social acceptance of people with brain health conditions. Our research programs tackle some of the most complex challenges in neuroscience, and our pipeline is focused on bringing forward transformative treatments for brain diseases for which there are few, if any therapeutic options.
For additional information, we encourage you to visit our corporate site www.lundbeck.com (https://www.lundbeck.com/global) and connect with us via LinkedIn (https://www.linkedin.com/company/lundbeck/).
Ottiliavej 9, 2500 Valby, Denmark
+45 3630 1311
info@lundbeck.com